Side effects and watch-outs
- Injection site reaction
- Fatigue (immune activation — first 1–2 weeks)
- Mild fever on initiation
- Rare: autoimmune flare in predisposed individuals
- Do not use in organ transplant recipients without physician oversight
Peptide / Immune
Thymosin Alpha-1 (Tα1)
28-amino acid thymic peptide. FDA-approved (Zadaxin) in many countries for hepatitis B, hepatitis C and immunodeficiency. Potent T-cell and NK cell upregulator. Used in oncology, chronic infections, and post-COVID recovery.
Educational reference only. This page does not diagnose, prescribe, or replace care from a licensed professional. Laws, availability, and clinical appropriateness vary by location.